semaglutide plus cagrilintide Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study Cagrilintide vs Semaglutide: Different Paths

Both contain semaglutide, but Wegovy is licensed for weight management at doses up to 2.4 mg a week (and 7.2 mg a week from 2026), while Ozempic is licensed for type 2 diabetes at doses up to 2 mg a week

The Ozempic vs Mounjaro comparison is therefore more accurately framed as: semaglutide (at diabetes doses, off-licence for weight loss) vs tirzepatide (licensed for weight management)

If you dont continue to use your prescription as directed, it will not continue to treat your type 2 diabetes or weight-related medical problems, both of which are chronic conditions

Suicide and self-harm events with GLP-1 receptor agonists in adults with diabetes or obesity: a systematic review and meta-analysis

Dans un contexte de croissance dmographique et de diversification des services mdicaux offerts par le CHR de Sokod, lactivit du laboratoire ne cesse d'augmenter